ConductScience.org, home

Trial · NCT07911995

Registered outcomes19

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCore Phase: Change From Baseline in Time-to-Stand-from-Supine (TTSTAND) VelocityBaseline to Week 24Change from baseline to Week 24 in TTSTAND velocity.
PrimaryExtension Phase: Incidence of Adverse EventsFirst dose through Week 96Safety and Tolerability.
SecondaryCore Phase: Change From Baseline in Stride Velocity 95th Centile (SV95C)Baseline to Week 24Change from baseline to Week 24 in SV95C measured using wearable sensor technology.
SecondaryCore Phase: Change From Baseline in 10-Meter Walk/Run (10MWR) velocityBaseline to Week 24Change From Baseline in Functional Test Performance.
SecondaryCore Phase: Change From Baseline in Time-to-Climb-4-Stairs (TTCLIMB) velocityBaseline to Week 24Change From Baseline in Functional Test Performance.
SecondaryCore Phase: Incidence of Adverse EventsFirst dose through Week 24Safety and Tolerability.
SecondaryExtension Phase: Time to Treatment Discontinuation Due to Adverse EventsUp to Week 96Time to permanent discontinuation of study treatment due to an adverse event.
SecondaryExtension Phase: Change From Baseline in Weight and BMI Z-ScoresBaseline to Week 96Change from baseline in weight and body mass index (BMI) Z-scores.
SecondaryExtension Phase: Change From Baseline in Cushingoid FeaturesBaseline to Week 96Change from baseline in Cushingoid features.
SecondaryExtension Phase: Change From Baseline in Glucose MetabolismBaseline to Week 96Change from baseline in fasting glucose and fasting serum insulin.
SecondaryExtension Phase: Change From Baseline in PARS-III ScoreBaseline to Week 96Change from baseline in Personal Adjustment and Role Skills Scale (PARS-III) score.
SecondaryExtension Phase: Change From Baseline in Bone Mineral DensityBaseline to Week 96Change from baseline in bone mineral density assessed by dual-energy X-ray absorptiometry (DXA).
SecondaryExtension Phase: Vertebral Fracture AssessmentBaseline to Week 96Assessment of vertebral fractures by lateral thoracolumbar spine X-ray.
SecondaryExtension Phase: Change From Baseline in Height Z-ScoreBaseline to Week 96Change from baseline in height Z-score.
SecondaryExtension Phase: Change From Baseline in Bone AgeBaseline to Week 96Change from baseline in bone age assessed by left hand X-ray.
SecondaryExtension Phase: Change From Baseline in TTSTAND VelocityBaseline to Week 96Change From Baseline in Functional Test Performance.
SecondaryExtension Phase: Change From Baseline in 10MWR VelocityBaseline to Week 96Change From Baseline in Functional Test Performance.
SecondaryExtension Phase: Change From Baseline in TTCLIMB VelocityBaseline to Week 96Change From Baseline in Functional Test Performance.
SecondaryExtension Phase: Change From Baseline in SV95CBaseline to Week 96Change from baseline in SV95C measured using wearable sensor technology.

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07911995/registered